Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 12, Issue 2, Pages 77-84Publisher
SPRINGER
DOI: 10.1007/s11154-011-9178-0
Keywords
Thrombosis; Estrogen; Thrombophilia; Myocardial infraction; Stroke
Categories
Ask authors/readers for more resources
Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available